This investigation provides valuable information that can be used to determine the utility of the ADAMTS18 gene as a potential novel biomarker for ccRCC diagnosis and prognosis and a potential ccRCC therapeutic target. The gene discussed is ADAMTS18; the disease is nonpapillary renal cell carcinoma.